Literature DB >> 16220479

The sequential analysis of repeated binary responses: a score test for the case of three time points.

Marina Roshini Sooriyarachchi1, John Whitehead, Anne Whitehead, Kim Bolland.   

Abstract

In this paper a robust method is developed for the analysis of data consisting of repeated binary observations taken at up to three fixed time points on each subject. The primary objective is to compare outcomes at the last time point, using earlier observations to predict this for subjects with incomplete records. A score test is derived. The method is developed for application to sequential clinical trials, as at interim analyses there will be many incomplete records occurring in non-informative patterns. Motivation for the methodology comes from experience with clinical trials in stroke and head injury, and data from one such trial is used to illustrate the approach. Extensions to more than three time points and to allow for stratification are discussed.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16220479     DOI: 10.1002/sim.2339

Source DB:  PubMed          Journal:  Stat Med        ISSN: 0277-6715            Impact factor:   2.373


  3 in total

1.  Advancing clinical trial design in pulmonary hypertension.

Authors:  Andy P Grieve; Shien-Chung Chow; John Curram; Stephen Dawe; Lutz O Harnisch; Noreen R Henig; Hsien Ming J Hung; D Dunbar Ivy; Steven M Kawut; Mohammad H Rahbar; Shen Xiao; Martin R Wilkins
Journal:  Pulm Circ       Date:  2013-01       Impact factor: 3.017

2.  Interim analysis for binary outcome trials with a long fixed follow-up time and repeated outcome assessments at pre-specified times.

Authors:  Sameer Parpia; Jim A Julian; Chushu Gu; Lehana Thabane; Mark N Levine
Journal:  Springerplus       Date:  2014-06-26

3.  A comparison of methods for treatment selection in seamless phase II/III clinical trials incorporating information on short-term endpoints.

Authors:  Cornelia Ursula Kunz; Tim Friede; Nicholas Parsons; Susan Todd; Nigel Stallard
Journal:  J Biopharm Stat       Date:  2015       Impact factor: 1.051

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.